Impaired Erythropoietin Response to Anemia in Patients with Lymphocytic Malignancies

Your Location：

Home >

Browse articles >

中国医学科学杂志（英文版） 2007年第3期页码：203-204

Updated：2024-04-10

- Impaired Erythropoietin Response to Anemia in Patients with Lymphocytic Malignancies
- Affiliations：
- Author bio：
- Funds：
- DOI：
  中图分类号： R733
- 纸质出版日期：2007
- Accepted：
Scan QR Code
[1].Impaired Erythropoietin Response to Anemia in Patients with Lymphocytic Malignancies[J].Chinese Medical Sciences Journal,2007(03):203-204.

Bing Han1, Yuan-kai Shi2, Jun Zhu3, et al. Impaired Erythropoietin Response to Anemia in Patients with Lymphocytic Malignancies[J]. Chinese medical sciences journal, 2007, (3): 203-204.
[1].Impaired Erythropoietin Response to Anemia in Patients with Lymphocytic Malignancies[J].Chinese Medical Sciences Journal,2007(03):203-204. DOI：

Bing Han1, Yuan-kai Shi2, Jun Zhu3, et al. Impaired Erythropoietin Response to Anemia in Patients with Lymphocytic Malignancies[J]. Chinese medical sciences journal, 2007, (3): 203-204. DOI：

<正>Patients with lymphocytic malignancies like Non-Hodgkin’s lymphoma （NHL）

multiple myeloma （MM）

and chronic lymphocytic leukemia （CLL） are often complicated with anemia. In this prospective study

we devised a carefully controlled erythropoietin （Epo） level measurement in anemic or non-anemic patients with lymphocytic malignancies

in order to determine whether the response of Epo was decreased in anemic patients.

<正>Patients with lymphocytic malignancies like Non-Hodgkin’s lymphoma （NHL）

multiple myeloma （MM）

and chronic lymphocytic leukemia （CLL） are often complicated with anemia. In this prospective study

we devised a carefully controlled erythropoietin （Epo） level measurement in anemic or non-anemic patients with lymphocytic malignancies

in order to determine whether the response of Epo was decreased in anemic patients.

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

关联资源

暂无数据